Our achievements. Our accomplishments. Our impact.



  • Establishing a Community

    By prioritizing multidisciplinary research partnerships among stem cell researchers across Canada, the Stem Cell Network integrated the country’s previously fractured landscape into a comprehensive and globally respected research community.

    READ STORY

  • Cancer Stem Cells

    A seminal Canadian discovery demonstrated that cancer stem cells are a significant reason for high relapse rates after cancer treatments. In recognition of this, the Stem Cell Network has invested heavily finding ways to target and attack them.

    READ STORY

  • Student Engagement

    In collaboration with educators, researchers and graduate-level trainees, the Stem Cell Network has directly engaged thousands of high school students across the country to enhance their learning about various aspects of stem cell research.

    READ STORY

  • Public Engagement

    The Stem Cell Network has elevated the level of public discourse and understanding about stem cells in Canada by engaging Canadians in artistic, accessible and innovative explorations of emerging issues in the field and by becoming an active and respected presence online.

    READ STORY

  • Stem Cell Genomics

    SCN’s Gene Expression Project was made possible through the Network’s collaborative approach to research, and the Project’s use of a single centre to undertake a standardized analysis of hundreds of stem cell lines allowed for the creation of pertinent data and meta-data to be accessed by thousands of researchers around the world.

    READ STORY

  • Commercialization

    The Stem Cell Network’s catalysis of commercialization of stem cell research has led to 399 patent applications, 60 issued patents, 43 licenses granted, the growth or launch of 11 start-up biotechnology companies and the establishment of a new Centre for the Commercialization of Regenerative Medicine (CCRM) to develop a strong industry presence in several emerging technology areas likely to be crucial to the future delivery of stem cell-based therapies.

    READ STORY